美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=GLYRX-PF"
符合检索条件的记录共 8 条
共 1 页，当前第 1 页
返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
GLYRX-PF 210997 001 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 0.2MG/ML (0.2MG/ML) Yes Yes 2018/07/11 2018/07/11 EXELA PHARMA Prescription
GLYRX-PF 210997 001 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 0.2MG/ML (0.2MG/ML) Yes Yes 2018/07/11 2018/07/11 EXELA PHARMA Prescription
GLYRX-PF 210997 002 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 0.4MG/2ML (0.2MG/ML) Yes Yes 2018/07/11 2018/07/11 EXELA PHARMA Prescription
GLYRX-PF 210997 002 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 0.4MG/2ML (0.2MG/ML) Yes Yes 2018/07/11 2018/07/11 EXELA PHARMA Prescription
GLYRX-PF 210997 003 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 1MG/5ML (0.2MG/ML) Yes Yes 2018/07/11 2020/04/09 EXELA PHARMA Prescription
GLYRX-PF 210997 003 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 1MG/5ML (0.2MG/ML) Yes Yes 2018/07/11 2020/04/09 EXELA PHARMA Prescription
GLYRX-PF 210997 004 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 0.6MG/3ML (0.2MG/ML) Yes Yes 2018/07/11 2020/12/14 EXELA PHARMA Prescription
GLYRX-PF 210997 004 NDA GLYCOPYRROLATE SOLUTION;INTRAMUSCULAR, INTRAVENOUS 0.6MG/3ML (0.2MG/ML) Yes Yes 2018/07/11 2020/12/14 EXELA PHARMA Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database